Agilent Technologies Introduces First Commercial Software for Metabolic Flux Analysis
April 18 2016 - 11:00AM
Business Wire
MassHunter VistaFlux Will Help Cancer
Researchers Better Understand Metabolic Pathways
Agilent Technologies Inc. (NYSE:A) today introduced new software
to help researchers analyze qualitative metabolic flux—tracking the
different pathways a metabolite participates in under different
biological experiments. This analytical capability is of particular
interest to cancer researchers who want to better understand the
metabolic pathways associated with cancer cells.
Agilent introduced VistaFlux at the annual meeting of the
American Association for Cancer Research today in New Orleans.
“MassHunter VistaFlux speeds up clinical research data analysis
so scientists can quickly understand the underlying cause of
diseases, such as cancer,” said Monty Benefiel, Agilent vice
president and general manager, Mass Spectrometry Division.
“The new Agilent VistaFlux will be an essential tool for us,”
said Dr. Simon Thain, metabolic phenotyping manager, GeneMill,
University of Liverpool. “I have been waiting 10 years for software
like VistaFlux. It will allow my lab to complete flux projects in a
fraction of the time.”
VistaFlux, the first commercially available software of its
kind, is the newest addition to the company’s comprehensive suite
of software for metabolomics and the MassHunter MS software
portfolio.
With VistaFlux software, researchers will be able to more easily
analyze data from targeted metabolic flux experiments when using
Agilent time-of-flight and quadrupole time-of-flight liquid
chromatography mass spectrometry systems.
“VistaFlux enables cutting-edge, targeted, isotopologue data
extraction and pathway visualization of flux results for greater
biological understanding,” Benefiel said. “It will enable
multidisciplinary research teams to quickly mine and interpret the
data they collect from targeted qualitative flux experiments.”
About Agilent Technologies
Agilent Technologies Inc. (NYSE:A), a global leader in life
sciences, diagnostics and applied chemical markets, is the premier
laboratory partner for a better world. Agilent works with customers
in more than 100 countries, providing instruments, software,
services and consumables for the entire laboratory workflow. The
company generated revenue of $4.04 billion in fiscal 2015 and
employs about 12,000 people worldwide. Information about Agilent is
available at www.agilent.com.
NOTE TO EDITORS: Further technology, corporate citizenship and
executive news is available at www.agilent.com/go/news.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160418005334/en/
Agilent Technologies Inc.Michele Moyer, +1
408-553-7211michele.moyer@agilent.com
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Mar 2024 to Apr 2024
Agilent Technologies (NYSE:A)
Historical Stock Chart
From Apr 2023 to Apr 2024